ASSET PURCHASE AGREEMENTAsset Purchase Agreement • December 14th, 2022 • Harrow Health, Inc. • Pharmaceutical preparations • New York
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of this 13th day of December, 2022, by and among (i) Novartis Technology LLC (“NTLLC”), a limited liability company organized under the laws of the State of Delaware and having its principal place of business at One Health Plaza, East Hanover, New Jersey, 07936, Novartis Innovative Therapies AG, a company organized under the laws of Switzerland and having its principal place of business at Suurstoffi 14, 6343 Rotkreuz, Switzerland (“NOAG” and NOAG and NTLLC being collectively referred to as “Novartis”) and (ii) Harrow Health, Inc., a corporation formed under the laws of Delaware and located at 102 Woodmont Blvd. Suite 610, Nashville, Tennessee 37205 (“Harrow Health”), Harrow Eye, LLC, a limited liability company formed under the laws of Delaware and located at 102 Woodmont Blvd. Suite 610, Nashville, Tennessee 37205 (“Harrow Eye”) and Harrow IP, LLC, a limited liability company formed under the laws of Delaware and located at
